Dermatologists found a decreased risk of infection in patients with psoriasis using some of the newer, more targeted medications compared to those taking methotrexate, a drug widely used since the 1960s as a first line treatment for moderate-to-severe psoriasis.
Click here for original story, Some biologic treatments for psoriasis may be safer for patients
Source: ScienceDaily